Safety and Immunogenicity of Increasing Doses of a Clostridium difficile Toxoid Vaccine Administered to Healthy Adults

Clostridium difficile is a major cause of nosocomial diarrhea in industrialized countries. Although most illnesses respond to available therapy, infection can increase morbidity, prolong hospitalization, and produce life-threatening colitis. Vaccines are being explored as an alternative means for pr...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Infect Immun
Asıl Yazarlar:	Kotloff, Karen L., Wasserman, Steven S., Losonsky, Genevieve A., Thomas, William, Nichols, Richard, Edelman, Robert, Bridwell, Margaret, Monath, Thomas P.
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 2001
Konular:	Microbial Immunity and Vaccines
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97978/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11159994/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.2.988-995.2001
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Safety and Immunogenicity of Increasing Doses of a Clostridium difficile Toxoid Vaccine Administered to Healthy Adults

Benzer Materyaller